We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.93%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$16.7B
AUM Growth
+$329M
Cap. Flow
-$710M
Cap. Flow %
-4.25%
Top 10 Hldgs %
19.03%
Holding
2,687
New
132
Increased
900
Reduced
1,002
Closed
108

Top Buys

Rank Stock Value
1
PGR icon
Progressive
PGR
+$232M
2
BNL icon
Broadstone Net Lease
BNL
+$66.5M
3
APH icon
Amphenol
APH
+$64M
4
SNPS icon
Synopsys
SNPS
+$46.8M
5
XLNX
Xilinx Inc
XLNX
+$46.5M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$78M
2
KEYS icon
Keysight
KEYS
+$69.7M
3
ADP icon
Automatic Data Processing
ADP
+$68.4M
4
CSCO icon
Cisco
CSCO
+$60.5M
5
OMC icon
Omnicom Group
OMC
+$52.8M

Sector Composition

Rank Sector Weight
1 Technology 23.23%
2 Healthcare 13.49%
3 Financials 11.88%
4 Consumer Discretionary 9.14%
5 Industrials 8.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASXC
2301
DELISTED
Asensus Surgical, Inc.
ASXC
$2K ﹤0.01%
7,172
CONN
2302
DELISTED
Conn's Inc.
CONN
$2K ﹤0.01%
+203
New +$2.19K
CAMP
2303
DELISTED
CalAmp Corp.
CAMP
$2K ﹤0.01%
16
+5
+45% +$937
LBAI
2304
DELISTED
Lakeland Bancorp Inc
LBAI
$2K ﹤0.01%
294
-191
-39% -$2.02K
ROCC
2305
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$2K ﹤0.01%
+300
New +$3.18K
ZNH
2306
DELISTED
China Southern Airlines Company Limited
ZNH
$2K ﹤0.01%
110
HMLP
2307
DELISTED
HOEGH LNG PARTNERS LP
HMLP
$2K ﹤0.01%
+200
New +$2.11K
TPTX
2308
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$2K ﹤0.01%
28
+11
+65% +$766
BPYU
2309
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
$2K ﹤0.01%
222
JCAP
2310
DELISTED
Jernigan Capital, Inc.
JCAP
$2K ﹤0.01%
150
IDXG
2311
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$2K ﹤0.01%
797
MBT
2312
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$2K ﹤0.01%
277
-102
-27% -$926
CHA
2313
DELISTED
China Telecom Corporation, LTD
CHA
$2K ﹤0.01%
94
AAOI icon
2314
Applied Optoelectronics
AAOI
$7.23B
$1K ﹤0.01%
131
ALNT icon
2315
Allient
ALNT
$1.47B
$1K ﹤0.01%
45
AMED
2316
DELISTED
Amedisys
AMED
$1K ﹤0.01%
5
AMPH icon
2317
Amphastar Pharmaceuticals
AMPH
$899M
$1K ﹤0.01%
104
-98
-49% -$1.97K
ANIP icon
2318
ANI Pharmaceuticals
ANIP
$1.83B
$1K ﹤0.01%
54
-12
-18% -$357
ARLP icon
2319
Alliance Resource Partners
ARLP
$3.37B
$1K ﹤0.01%
700
ARMK icon
2320
Aramark
ARMK
$15.1B
$1K ﹤0.01%
65
-26,877
-100% -$479K
CVSA
2321
Covista Inc
CVSA
$4.3B
$1K ﹤0.01%
77
-30
-28% -$968
ATI icon
2322
ATI
ATI
$24.8B
$1K ﹤0.01%
136
+18
+15% +$166
AVT icon
2323
Avnet
AVT
$7.12B
$1K ﹤0.01%
50
-589
-92% -$16K
BFC icon
2324
Bank First Corp
BFC
$1.68B
$1K ﹤0.01%
+27
New +$1.68K
BFS
2325
Saul Centers
BFS
$850M
$1K ﹤0.01%
71

Similar funds

Glenmede Trust's Q3 2020 Portfolio in Review

As of Q3 2020, Glenmede Trust held 2,687 positions worth $16.7B, up 2% from $16.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Glenmede Trust withdrew a net $710M in Q3 2020, closing 108 positions and reducing 1,002 holdings. Its most notable exit was IBERIABANK Corp, an estimated $18.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Glenmede Trust opened a new position in Broadstone Net Lease worth $67.3M.

  • Glenmede Trust's largest Q3 2020 buy was Broadstone Net Lease: 4,009,897 shares worth $67.3M.
  • Glenmede Trust added most to Progressive in Q3 2020, an estimated $232M increase.
  • Glenmede Trust's biggest Q3 2020 reduction was Apple, cutting an estimated $78M.
  • Glenmede Trust fully exited IBERIABANK Corp in Q3 2020, selling an estimated $18.1M.
  • Glenmede Trust's ten largest holdings make up 19% of its $16.7B portfolio in Q3 2020.
  • Glenmede Trust opened 132 new positions and closed 108 in Q3 2020.
  • Glenmede Trust's portfolio value rose 2% quarter-over-quarter to $16.7B.

Based on Glenmede Trust's 13F filing for Q3 2020, filed 16 Nov 2020.